C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2006
12/26/2006	US7153809 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
12/21/2006	WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006	WO2006085049A3 Michael addition product and schiff's base aromachemicals
12/21/2006	WO2006085048A3 Pro-fragrance and pro-flavorant compositions
12/21/2006	US20060287402 Cathepsin inhibitors
12/21/2006	US20060287396 4-aryl quinols and analogs thereof as therapeutic agents
12/21/2006	US20060287393 Novel compounds, their preparation and use
12/21/2006	US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/21/2006	US20060287306 Compounds to treat alzheimer's disease
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287291 such as 2-Methoxy-5-methyl-N-[7-(piperazin-1-ylcarbonyl)-1-benzofuran-5-yl]benzenesulfonamide for treating disorders related to 5-HT6 receptor related disorders such as obesity, type II diabetes, anxiety, depression, panic attacks, memory/sleep/cognitive disorders, epilepsy, obsessive compulsive disorder
12/21/2006	DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them
12/21/2006	CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/20/2006	EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1732931A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL
12/20/2006	EP1732930A2 2,4,6-phenylsubstituted cyclic ketoenoles
12/20/2006	EP1732882A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
12/20/2006	EP1732537A1 Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia
12/20/2006	EP1732536A2 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
12/20/2006	EP1732532A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
12/20/2006	EP1732514A1 Crystalline composition containing escitalopram oxalate
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882563A Antidiabetic compounds comprising benzofuran and benzothiophene derivatives
12/20/2006	CN1882562A Benzofurans and benzothiophenes
12/20/2006	CN1882558A Liquid cyclohexane-tricarboxylic acid anhydride
12/20/2006	CN1882557A 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
12/20/2006	CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/20/2006	CN1882528A Organic compounds
12/20/2006	CN1882527A Biphenyloxy-acids
12/20/2006	CN1882523A Novel phenol derivative, and anti-trypanosomiasis medicine with the phenol derivative as effective ingredient
12/20/2006	CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/20/2006	CN1882329A 4-(1-benzofuran-3-yl-methylideneaminoxy.propoxy))-benzoic acid derivatives and related compounds as PAI-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombosis
12/20/2006	CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes
12/20/2006	CN1880293A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
12/20/2006	CN1290850C Extraction method of ginkgolactone B and ginkgo lactone in ginkgo leaf
12/20/2006	CN1290838C Sulfonated derivative of andrographolide and combination of medication
12/19/2006	US7151185 Converting lactones such as gamma-butyrolactone to their alpha-methylene substituted forms using an oxynitride catalyst derived from an aluminum compound, phosphoric acid, optionally a tetraalkoxysilane and ammonia
12/19/2006	US7151184 Preparation of phthalic anhydride
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006	CA2209539C Phenol-free stabilization of polyolefin fibres
12/19/2006	CA2127242C Extraction of toxic organic contaminants from wood
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006131465A1 Reversibly thermochromic compositions
12/14/2006	WO2006131398A2 Inhibitors of soluble adenylate cyclase
12/14/2006	WO2006131304A2 Process for preparing renin inhibitors
12/14/2006	US20060281929 reacting an ethylene oxide with carbon dioxide in the presence of catalysts in chemical reactors to obtain reaction mixtures containing ethylene carbonate; continous processing; preventing fouling in heat exchangers
12/14/2006	US20060281925 Method for producing coupling compound
12/14/2006	US20060281811 Synthesis of taxol enhancers
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
12/14/2006	CA2608575A1 Process for preparing renin inhibitors
12/14/2006	CA2606692A1 Inhibitors of soluble adenylate cyclase
12/13/2006	EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
12/13/2006	EP1730140A1 Opioid receptor antagonists
12/13/2006	EP1729759A1 Salvinorin derivatives and uses thereof
12/13/2006	EP1148880B1 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/13/2006	CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient
12/13/2006	CN1876656A Triptolide purification method
12/13/2006	CN1876654A Preparation method for important intermediate of protease inhibitor
12/13/2006	CN1876641A Method for purifying salvianolic acid B
12/13/2006	CN1876233A Furfuraldehyde hydrogenation catalyst and method for preparing the same
12/13/2006	CN1289506C Gambogic aid compound complex, its preparing method and medicinal composition containing the complex as active ingredient
12/13/2006	CN1289505C Novel compound gamboges new acid chemical structure, medicine preparation using said compound as active component, its application
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006	CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289466C Pharmaceutical compounds
12/12/2006	US7148383 Can be used to prepare elements and devices suitable for use in optical communications
12/12/2006	US7148364 Reacting 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran bromide(or chloride) with a cyanide source in presence of an iodide and a suitable solvent selected from the group consisting of amides, amines and polyethers, treating with cyanide reversal regeant
12/12/2006	US7148363 Esterification to get cyclic acrylate compounds; used as raw material for functional polymers, pharmaceuticals, pesticides, semiconductor lithography
12/12/2006	US7148318 Method for producing polytetrahydrofurane having a low color indices
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148254 2-Phenylbenzofuran derivatives, a process for preparing them, and their use
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148225 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/07/2006	WO2006129771A1 Tetracarboxylic acid or polyesterimide thereof, and process for production of the same
12/07/2006	WO2006129318A2 Benzofuran derivatives with therapeutic activities
12/07/2006	WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006	US20060276661 Three-layered or four-layered catalyst systems for producing phthalic anhydride
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276535 )-{3-[4-(2-Ethylamino-ethoxy)-3,5-diiodo-benzoyl]-benzofuran-2-yl}-acetic acid sec-butyl ester; amiodarone derivatives; congestive heart failure, ischemic cardiomyopathy, atrial fibrillation, ventricular tachycardia; side effect reduction: pharmacolkinetics, oral bioavailability, nontoxic
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276504 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye
12/07/2006	US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006	CA2610274A1 Benzofuran derivatives with therapeutic activities
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727883A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
12/06/2006	EP1727822A1 Novel compounds for modulating cell proliferation
12/06/2006	EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	CN1875013A Method for the preparation of citalopram
12/06/2006	CN1875012A 2-phenylbenzofuran derivatives, a process for preparing them, and their use
12/06/2006	CN1874987A Method for producing ester condensed product

1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 472